AQR Capital Management
LOXO

AQR Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

AQR Capital Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-31,470
Closed -$4.41M – 2288
2018
Q4 		$4.41M Buy
31,470
+5,802
+23% +$881K 0.01% 983
2018
Q3 		$4.38M Buy
25,668
+1,790
+7% +$301K ﹤0.01% 1061
2018
Q2 		$4.14M Buy
23,878
+6,288
+36% +$945K ﹤0.01% 1109
2018
Q1 		$2.03M Sell
17,590
-6,174
-26% -$657K ﹤0.01% 1352
2017
Q4 		$2M Sell
23,764
-3,318
-12% -$277K ﹤0.01% 1382
2017
Q3 		$2.5M Buy
27,082
+10,685
+65% +$830K ﹤0.01% 1300
2017
Q2 		$1.31M Buy
16,397
+8,280
+102% +$459K ﹤0.01% 1565
2017
Q1 		$342K Sell
8,117
-3,498
-30% -$144K ﹤0.01% 1989
2016
Q4 		$373K Sell
11,615
-5,172
-31% -$133K ﹤0.01% 2006
2016
Q3 		$439K Buy
16,787
+2,515
+18% +$65.8K ﹤0.01% 1982
2016
Q2 		$331K Hold
14,272
– – ﹤0.01% 1993
2016
Q1 		$390K Buy
14,272
+3,056
+27% +$63.9K ﹤0.01% 1915
2015
Q4 		$319K Buy
+11,216
New +$301K ﹤0.01% 2014

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

AQR Capital Management's LOXO Position: Q1 2019 in Review

AQR Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 31,470 shares — an estimated $4.41M sold.

AQR Capital Management first reported a position in LOXO in Q4 2015 and held it in 13 quarters. The position peaked at $4.41M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • AQR Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • AQR Capital Management sold 31,470 Loxo Oncology, Inc shares in Q1 2019, an estimated $4.41M.
  • AQR Capital Management first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 13 quarters.
  • AQR Capital Management's Loxo Oncology, Inc position peaked at $4.41M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.